دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus and Association With All?Cause Mortality
Katherine P. Liao Jie Huang Zeling He Gabrielle Cremone Ethan Lam Jon M. Hainer Victoria Morgan Courtney Bibbo Marcelo Di Carli
doi : 10.1002/acr.24108
Volume73, Issue2,Pages 159-165
Coronary microvascular dysfunction (CMD) is a predictor of cardiac death in diabetes mellitus (DM) independent of traditional cardiovascular (CV) risk factors. Rheumatoid arthritis (RA) is a chronic inflammatory condition, with excess CV risk compared to the general population, in which CMD is hypothesized to play a role; however, there are limited data on CMD in RA and any association with clinical outcomes. The objective of this study was to compare the prevalence of CMD in RA to that in DM and to test the association with all?cause mortality.
Improved Pregnancy Outcome in Patients With Rheumatoid Arthritis Who Followed an Ideal Clinical Pathway
Alessandra Bortoluzzi Laura Andreoli Greta Carrara Véronique Ramoni Federica Rumi Melissa Padovan Marcello Govoni Angela Tincani and Carlo Alberto Scirè the Record-Linkage on Rheumatic Diseases Study of the Italian Society for Rheumatology
doi : 10.1002/acr.24116
Volume73, Issue2,Pages 166-172
To assess the effect of optimal management of pregnancy on a composite outcome of miscarriage and complicated birth among women with rheumatoid arthritis (RA).
Finger Joint Cartilage Evaluated by Semiquantitative Ultrasound Score in Patients With Rheumatoid Arthritis
Takehisa Ogura Ayako Hirata Norihide Hayashi Chihiro Imaizumi Hideki Ito Sayaka Takenaka Yuki Inoue Yuto Takakura Kennosuke Mizushina Takaharu Katagiri Hideto Kameda
doi : 10.1002/acr.24101
Volume73, Issue2,Pages 173-179
Joint destruction in rheumatoid arthritis (RA) includes both bone and cartilage lesions. Since joint space narrowing (JSN) is not a direct evaluation of cartilage using radiography, we aimed to examine the validity of ultrasound (US) cartilage evaluation using a semiquantitative method in patients with RA.
Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis
Vanessa L. Kronzer Cynthia S. Crowson Jeffrey A. Sparks Elena Myasoedova John Davis III
doi : 10.1002/acr.24115
Volume73, Issue2,Pages 180-187
Since comorbidities such as autoimmune diseases may be associated with rheumatoid arthritis (RA) risk, we hypothesized that a family history of these other conditions might also predict RA. Therefore, we aimed to determine the association between family history of 79 comorbidities and RA.
Roles of Postdiagnosis Accumulation of Morbidities and Lifestyle Changes in Excess Total and Cause?Specific Mortality Risk in Rheumatoid Arthritis
Kazuki Yoshida Tzu?Chieh Lin Melissa Y. Wei Susan Malspeis Su H. Chu Carlos A. Camargo Jr Benjamin A. Raby Hyon K. Choi Sara K. Tedeschi Medha Barbhaiya Bing Lu Karen H. Costenbader Elizabeth W. Karlson Jeffrey A. Sparks
doi : 10.1002/acr.24120
Volume73, Issue2,Pages 188-198
To elucidate how postdiagnosis multimorbidity and lifestyle changes contribute to the excess mortality of rheumatoid arthritis (RA).
Prevalence of Rheumatoid Arthritis and Drug Dispensing Patterns Among Medicaid and Medicaid–Medicare Dually Eligible Beneficiaries in Puerto Rico
José J. Hern?ndez-Mu?oz Wenfei Wei Radames Sierra-Zorita
doi : 10.1002/acr.24330
Volume73, Issue2,Pages 199-206
To estimate the prevalence of rheumatoid arthritis (RA) in Puerto Rico, to describe disease?modifying antirheumatic drug (DMARD) dispensing patterns by prescriber specialty, and to illustrate the impact of RA case definition on the estimated prevalence.
Treat?to?Target Approach in Rheumatoid Arthritis: A Quality Improvement Trial
Sonali P. Desai Cianna Leatherwood Malka Forman Eunji Ko Emma Stevens Maura Iversen Chang Xu Bing Lu Daniel H. Solomon
doi : 10.1002/acr.24114
Volume73, Issue2,Pages 207-214
Using a quality improvement approach, our objective was to integrate a treat?to?target approach for rheumatoid arthritis (RA) through routine electronic collection of patient?reported disease activity scores and a multidisciplinary learning collaborative for rheumatologists.
Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases
Lisa H. Buckley Rui Xiao Marissa J. Perman Andrew B. Grossman Pamela F. Weiss
doi : 10.1002/acr.24100
Volume73, Issue2,Pages 215-220
To estimate the incidence rate (IR) of psoriasis in children with inflammatory bowel disease (IBD), juvenile idiopathic arthritis (JIA), and chronic noninfectious osteomyelitis (CNO) with tumor necrosis factor inhibitor (TNFi) exposure as compared to children without TNFi exposure and to the general pediatric population.
Treatment Satisfaction With and Adherence to Disease?Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis
Anita Tollisen Berit Flat? Anne M. Selvaag Astrid Aasland Trude Ingebrigtsen Joachim Sagen Anners Lerdal
doi : 10.1002/acr.24113
Volume73, Issue2,Pages 221-231
To examine medication satisfaction and adherence and their relationships to disease variables and health?related quality of life (HRQoL) in adults with juvenile idiopathic arthritis (JIA).
Effects of Neurodynamic Mobilizations on Pain Hypersensitivity in Patients With Hand Osteoarthritis Compared to Robotic Assisted Mobilization: A Randomized Controlled Trial
Paolo Pedersini Kristin Valdes Raquel Cantero-Tellez Joshua A. Cleland Mark D. Bishop Jorge H. Villafa?e
doi : 10.1002/acr.24103
Volume73, Issue2,Pages 232-239
To evaluate the effectiveness of the neurodynamic mobilization techniques compared with passive robotic physiologic movement in patients with hand osteoarthritis (OA).
Foot Orthoses and Footwear for the Management of Patellofemoral Osteoarthritis: A Pilot Randomized Trial
Narelle Wyndow Kay M. Crossley Bill Vicenzino Kylie Tucker Natalie J. Collins
doi : 10.1002/acr.24098
Volume73, Issue2,Pages 240-249
To determine the feasibility of a full?scale randomized controlled trial (RCT) comparing foot orthoses and footwear to footwear alone in individuals with patellofemoral (PF) osteoarthritis (OA).
Podiatry Intervention Versus Usual General Practitioner Care for Symptomatic Radiographic Osteoarthritis of the First Metatarsophalangeal Joint: A Randomized Clinical Feasibility Study
Kade L. Paterson Rana S. Hinman Ben R. Metcalf Penny K. Campbell Hylton B. Menz David J. Hunter Kim L. Bennell
doi : 10.1002/acr.24107
Volume73, Issue2,Pages 250-258
To determine the feasibility of a clinical trial comparing a podiatry intervention to usual general practitioner (GP) care for people with first metatarsophalangeal (MTP) joint osteoarthritis (OA).
Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture: A General Population?Based Study
Lingyi Li Hui Xie Na Lu John M. Esdaile J. Antonio Avi?a?Zubieta
doi : 10.1002/acr.24112
Volume73, Issue2,Pages 259-265
Hip fractures have serious consequences, including a 1?year mortality rate of 30%. Population?based studies on hip fractures in individuals with systemic lupus erythematosus (SLE) are scarce. Our objective was to assess the independent risk of hip fractures in patients with newly diagnosed SLE compared to the general population, accounting for baseline and time?varying confounders.
Model to Determine the Cost?Effectiveness of Screening Psoriasis Patients for Psoriatic Arthritis
Nicolas Iragorri Glen Hazlewood Braden Manns Laura Bojke Eldon Spackman the Early Detection to Improve Outcome in People With Undiagnosed Psoriatic Arthritis Study Group
doi : 10.1002/acr.24110
Volume73, Issue2,Pages 266-274
Screening psoriasis patients for psoriatic arthritis (PsA) is intended to identify patients at earlier stages of the disease. Early treatment is expected to slow disease progression and delay the need for biologic therapy. Our objective was to determine the cost?effectiveness of screening for PsA in patients with psoriasis in Canada.
Factors Predictive of Radiographic Progression in Ankylosing Spondylitis
Ismail Sari Seunghun Lee George Tomlinson Sindhu R. Johnson Robert D. Inman Nigil Haroon
doi : 10.1002/acr.24104
Volume73, Issue2,Pages 275-281
Using a longitudinal observational cohort of ankylosing spondylitis (AS) patients, we sought to identify progression rates and factors predictive of spinal progression. As a secondary aim, we analyzed the effect of tumor necrosis factor inhibitor (TNFi) treatment on radiographic progression.
Spondyloarthritis and Outcomes in Pregnancy and Labor: A Nationwide Register?Based Cohort Study
Sofie M?rk Anne Voss S?ren M?ller Mette Bliddal
doi : 10.1002/acr.24111
Volume73, Issue2,Pages 282-288
To describe the prevalence of spondyloarthritis (SpA) and subtypes diagnosed prior to delivery in a nationwide population of pregnant women, and to estimate how SpA was associated with adverse pregnancy?related outcomes.
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases
Dirk Elewaut Jürgen Braun Jaclyn K. Anderson Dilek Arikan Su Chen Maja Hojnik Ann-Sophie De Craemer Jeffrey R. Curtis
doi : 10.1002/acr.24175
Volume73, Issue2,Pages 289-295
Adalimumab is approved for treatment of Crohn’s disease and ulcerative colitis. Thus, we postulated that exacerbation or new?onset of inflammatory bowel disease (IBD) would be rare events in patients treated with adalimumab for non?IBD indications. The objective was to evaluate the incidence of IBD adverse events (AEs) across adalimumab trials.
Intersectional Inequalities and Individual Heterogeneity in Chronic Rheumatic Diseases: An Intersectional Multilevel Analysis
Ali Kiadaliri Martin Englund
doi : 10.1002/acr.24109
Volume73, Issue2,Pages 296-304
To examine how intersections of multiple sociodemographic variables explain the individual heterogeneity in risk of being diagnosed with any of following chronic rheumatic diseases (CRDs): osteoarthritis (OA), gout, rheumatoid arthritis (RA), or spondyloarthritis (SpA).
